Amplatzer™ Amulet™ LAAO

AMPLATZER™ AMULET™
LAA OCCLUDER
STRUCTURAL INTERVENTIONS

Designed to treat patients with non-valvular atrial fibrillation (AF), who are at risk of ischemic stroke, the Amplatzer™ Amulet™ LAA Occluder offers complete closure of the left atrial appendage (LAA) and immediately eliminates the need for oral anticoagulants (OACs).¹

SWITCH TO THE REFERRAL VIEW For more information specific to neurology regarding LAA Occlusion

KEY FEATURES

Innovative dual seal technology

The Amulet™ Occluder's innovative dual seal technology leverages a proven Amplatzer™ design that has been trusted for over 20 years.¹

1

The lobe is designed to conform to different LAA anatomies including the hard to treat chicken wing and double lobe due to its proximal placement

2

The disc completely seals the LAA orifice creating a smooth surface to minimize the risk of a device-related thrombus (DRT) and offering a double sealing mechanism to decrease the risk of peri-device leaks (PDL)

3

Stabilizing wires secure the device in position to prevent embolization

FIND OUT MORE ABOUT:

GUIDELINES & RECOMMENDATIONS

More sizes for more anatomies

The Amulet™ Occluder offers a full range of sizes to ensure a precise fit across all LAA anatomies.

Physician education

Hear from physicians how the Amplatzer™ Amulet™ Occluder can benefit physicians and help patients live longer, fuller lives.

WATCH LAAO SUMMIT 2023

NEW VERSION AVAILABLE
GET THE AMPLATZER™ PORTFOLIO APP

The Amplatzer™ Portfolio App helps physicians determine which Amplatzer Structural Interventions device to use by suggesting applicable devices based on respective Instructions for Use.

Connext
TV

CONNECT TO THE LATEST
IN STRUCTURAL HEART
THERAPY

Find out more

TV

Dr Ingo Eitel explains why LAAO can be an option in ESKD patients

LAAO in ESKD patients

Dr Ingo Eitel explains why LAAO can be an option in ESKD patients

ESOC 2023: LAAO case

ESOC 2023: Meet the Expert: Marta Rubiera LAAO challenging case

LAAO 23: Tips and tricks - Complications

LAAO Summit 2023: Complications

LAAO 2023: Tips & tricks – Management of complications

LAAO 23: Tips and tricks - Successful implant

LAAO Summit 2023: Successful implant

LAAO 2023: Tips & tricks – How to make the most challenging LAAO case a successful implant

LAAO Summit 2023: Live Case: Salamanca

LAAO 2023: Live case from Salamanca

LAAO 23: Anatomy & Imaging - LAA anatomies

LAAO Summit 2023: LAA anatomies

LAAO 2023: Anatomy & imaging - LAA anatomies – A first look might be deceiving

LAAO Summit 2023: Anatomy & imaging – Panel

LAAO Summit 2023: Anatomy & imaging – Panel discussion

LAAO Summit 2023: Anatomy & imaging – The future

LAAO Summit 2023: Anatomy & imaging – Future promises and today's realities

LAAO Summit 2023: CT

LAAO 2023: Anatomy & imaging – Do we need CT to really understand the anatomy?

LAAO Summit 2023: LAAO therapies

LAAO 2023: What's new – Trends and recent data for LAA occlusion therapies

References

Amplatzer™ Amulet™ LAA Occluder Instructions for Use.
Lakkireddy D, Thaler D, Ellis CR, et al. Amplatzer™ Amulet™ Left Atrial Appendage Occluder versus Watchman™ device for stroke prophylaxis (Amulet IDE): A randomized, controlled trial. Circulation. 2021; 144(19) :1543–1552. doi.org/10.1161/CIRCULATIONAHA.121.057063.
Suradi HS, Hijazi ZM. Left atrial appendage closure: outcomes and challenges. Neth Heart J. 2017;25:143–151. doi.org/10.1007/s12471-016-0929-0.
Kakkar AK, Mueller I, Bassand J-P, et al. Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry. PLoS ONE. 2013; 8(5):e63479. doi.org/10.1371/journal.pone.0063479.
Baman JR, Mansour M, Heist EK, et al. Percutaneous left atrial appendage occlusion in the prevention of stroke in atrial fibrillation: a systematic review. Heart Failure Rev. 2018;23:191–208. doi.org/10.1007/s10741-018-9681-4.
European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery; Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010;31(19):2369–429. doi.org/10.1093/eurheartj/ehq278. Erratum in: Eur Heart J. 2011;32(9):1172. PMID: 20802247.